Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Mar 3;17(1):117.
doi: 10.1186/s13063-016-1225-4.

On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: study protocol for a hybrid design randomized controlled trial

Jemima A Frimpong  1 , Thomas D'Aunno  2 , David C Perlman  3 , Shiela M Strauss  4 , Alissa Mallow  5 , Diana Hernandez  6 , Bruce R Schackman  7 , Daniel J Feaster  8 , Lisa R Metsch  9
Affiliations
Randomized Controlled Trial

On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: study protocol for a hybrid design randomized controlled trial

Jemima A Frimpong et al. Trials. .

Abstract

Background: More than 1.2 million people in the United States are living with human immunodeficiency virus (HIV), and 3.2 million are living with hepatitis C virus (HCV). An estimated 25 % of persons living with HIV also have HCV. It is therefore of great public health importance to ensure the prompt diagnosis of both HIV and HCV in populations that have the highest prevalence of both infections, including individuals with substance use disorders (SUD).

Methods/design: In this theory-driven, efficacy-effectiveness-implementation hybrid study, we will develop and test an on-site bundled rapid HIV/HCV testing intervention for SUD treatment programs. Its aim is to increase the receipt of HIV and HCV test results among SUD treatment patients. Using a rigorous process involving patients, providers, and program managers, we will incorporate rapid HCV testing into evidence-based HIV testing and linkage to care interventions. We will then test, in a randomized controlled trial, the extent to which this bundled rapid HIV/HCV testing approach increases receipt of HIV and HCV test results. Lastly, we will conduct formative research to understand the barriers to, and facilitators of, the adoption, implementation, and sustainability of the bundled rapid testing strategy in SUD treatment programs.

Discussion: Novel approaches that effectively integrate on-site rapid HIV and rapid HCV testing are needed to address both the HIV and HCV epidemics. If feasible and efficacious, bundled rapid HIV/HCV testing may offer a scalable, potentially cost-effective approach to testing high-risk populations, such as patients of SUD treatment programs. It may ultimately lead to improved linkage to care and progress through the HIV and HCV care and treatment cascades.

Trial registration: ClinicalTrials.gov: NCT02355080 . (30 January 2015).

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow diagram of the trial design: on-site bundled rapid HIV/HCV testing randomized controlled trial (RCT). The diagram illustrates the progression of participants through the different points of the study
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Centers for Disease Control and Prevention: HIV in the united States: At A Glance. http://www.cdc.gov/hiv/statistics/basics/ataglance.html. Accessed 12 June 2015.
    1. Centers for Disease Control and Prevention: The ABCs of hepatitis. http://www.cdc.gov/hepatitis/Resources/Professionals/PDFs/ABCTable.pdf. Accessed 21 October 2012.
    1. Armstrong GL, Wasley AM, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144:705–714. doi: 10.7326/0003-4819-144-10-200605160-00004. - DOI - PubMed
    1. Soriano V, Vispo E, Labarga P, Medrano J, Barreiro P. Viral hepatitis and HIV co-infection. Antiviral Res. 2010;85:303–315. doi: 10.1016/j.antiviral.2009.10.021. - DOI - PubMed
    1. Thomas DL. The Challenge of Hepatitis C in the HIV-Infected Person. Annu Rev Med. 2008;59:473–485. doi: 10.1146/annurev.med.59.081906.081110. - DOI - PubMed

Publication types

MeSH terms

Associated data